Processa Pharmaceuticals Enters Material Definitive Agreement

Ticker: PCSA · Form: 8-K · Filed: Jul 1, 2025 · CIK: 1533743

Processa Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyProcessa Pharmaceuticals, Inc. (PCSA)
Form Type8-K
Filed DateJul 1, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, corporate-update

TL;DR

Processa Pharma signed a big deal on 6/27. Details TBD.

AI Summary

On June 27, 2025, Processa Pharmaceuticals, Inc. entered into a material definitive agreement. The company, formerly known as Heatwurx, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations industry. The filing does not disclose specific details of the agreement or any associated dollar amounts.

Why It Matters

This filing indicates a significant new contract or partnership for Processa Pharmaceuticals, which could impact its future operations and financial performance.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement, but the lack of specific details about the agreement introduces uncertainty.

Key Players & Entities

  • Processa Pharmaceuticals, Inc. (company) — Registrant
  • Heatwurx, Inc. (company) — Former company name
  • June 27, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation

FAQ

What is the nature of the material definitive agreement entered into by Processa Pharmaceuticals, Inc. on June 27, 2025?

The filing states that Processa Pharmaceuticals, Inc. entered into a material definitive agreement on June 27, 2025, but does not provide specific details about the nature of this agreement.

What was Processa Pharmaceuticals, Inc.'s former company name?

Processa Pharmaceuticals, Inc.'s former company name was Heatwurx, Inc., with a date of name change on October 28, 2011.

In which state is Processa Pharmaceuticals, Inc. incorporated?

Processa Pharmaceuticals, Inc. is incorporated in Delaware.

What is the principal executive office address for Processa Pharmaceuticals, Inc.?

The principal executive office address for Processa Pharmaceuticals, Inc. is 601 21st Street, Suite 300, Vero Beach, FL 32960.

What is the telephone number for Processa Pharmaceuticals, Inc.?

The telephone number for Processa Pharmaceuticals, Inc. is (772) 453-2899.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 1, 2025 regarding Processa Pharmaceuticals, Inc. (PCSA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.